Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2015 7
2016 1
2017 3
2018 3
2019 2
2021 2
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Free article. Clinical Trial.
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators. Robinson JG, et al. N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773378 Free article. Clinical Trial.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Environmental Risk Assessment Strategy for Nanomaterials.
Scott-Fordsmand JJ, Peijnenburg WJGM, Semenzin E, Nowack B, Hunt N, Hristozov D, Marcomini A, Irfan MA, Jiménez AS, Landsiedel R, Tran L, Oomen AG, Bos PMJ, Hund-Rinke K. Scott-Fordsmand JJ, et al. Int J Environ Res Public Health. 2017 Oct 19;14(10):1251. doi: 10.3390/ijerph14101251. Int J Environ Res Public Health. 2017. PMID: 29048395 Free PMC article.
Observing many researchers using the same data and hypothesis reveals a hidden universe of uncertainty.
Breznau N, Rinke EM, Wuttke A, Nguyen HHV, Adem M, Adriaans J, Alvarez-Benjumea A, Andersen HK, Auer D, Azevedo F, Bahnsen O, Balzer D, Bauer G, Bauer PC, Baumann M, Baute S, Benoit V, Bernauer J, Berning C, Berthold A, Bethke FS, Biegert T, Blinzler K, Blumenberg JN, Bobzien L, Bohman A, Bol T, Bostic A, Brzozowska Z, Burgdorf K, Burger K, Busch KB, Carlos-Castillo J, Chan N, Christmann P, Connelly R, Czymara CS, Damian E, Ecker A, Edelmann A, Eger MA, Ellerbrock S, Forke A, Forster A, Gaasendam C, Gavras K, Gayle V, Gessler T, Gnambs T, Godefroidt A, Grömping M, Groß M, Gruber S, Gummer T, Hadjar A, Heisig JP, Hellmeier S, Heyne S, Hirsch M, Hjerm M, Hochman O, Hövermann A, Hunger S, Hunkler C, Huth N, Ignácz ZS, Jacobs L, Jacobsen J, Jaeger B, Jungkunz S, Jungmann N, Kauff M, Kleinert M, Klinger J, Kolb JP, Kołczyńska M, Kuk J, Kunißen K, Kurti Sinatra D, Langenkamp A, Lersch PM, Löbel LM, Lutscher P, Mader M, Madia JE, Malancu N, Maldonado L, Marahrens H, Martin N, Martinez P, Mayerl J, Mayorga OJ, McManus P, McWagner K, Meeusen C, Meierrieks D, Mellon J, Merhout F, Merk S, Meyer D, Micheli L, Mijs J, Moya C, Neunhoeffer M, Nüst D, Nygård O, Ochsenfeld F, Otte G, Pechenkina AO… See abstract for full author list ➔ Breznau N, et al. Proc Natl Acad Sci U S A. 2022 Nov;119(44):e2203150119. doi: 10.1073/pnas.2203150119. Epub 2022 Oct 28. Proc Natl Acad Sci U S A. 2022. PMID: 36306328 Free PMC article.
22 results